Academic Journal

Cleaning, Chasing and Calming: Promising Paradigms of Senotherapy in Aging-Related Diseases.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Cleaning, Chasing and Calming: Promising Paradigms of Senotherapy in Aging-Related Diseases.
Συγγραφείς: Ran S; College of Pharmacy and Food, Key Laboratory of Research and Application of Ethnic Medicine Processing and Preparation on the Qinghai-Tibet Plateau, Southwest Minzu University, Chengdu 610041, China., Zhou S; College of Pharmacy and Food, Key Laboratory of Research and Application of Ethnic Medicine Processing and Preparation on the Qinghai-Tibet Plateau, Southwest Minzu University, Chengdu 610041, China., Ma H; College of Pharmacy and Food, Key Laboratory of Research and Application of Ethnic Medicine Processing and Preparation on the Qinghai-Tibet Plateau, Southwest Minzu University, Chengdu 610041, China., Zhang F; College of Pharmacy and Food, Key Laboratory of Research and Application of Ethnic Medicine Processing and Preparation on the Qinghai-Tibet Plateau, Southwest Minzu University, Chengdu 610041, China., Yang Y; Department of Pharmacy, Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China., Abulajiang M; College of Pharmacy and Food, Key Laboratory of Research and Application of Ethnic Medicine Processing and Preparation on the Qinghai-Tibet Plateau, Southwest Minzu University, Chengdu 610041, China., Yang X; Department of Pharmacy, Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China., Li S; College of Pharmacy and Food, Key Laboratory of Research and Application of Ethnic Medicine Processing and Preparation on the Qinghai-Tibet Plateau, Southwest Minzu University, Chengdu 610041, China., Zhang Q; Department of Pharmacy, Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.; Department of Pharmacy, Sichuan Provincial People's Hospital East Sichuan Hospital & Dazhou First People's Hospital, Dazhou, 635000, China.
Πηγή: International journal of biological sciences [Int J Biol Sci] 2026 Jul 20; Vol. 22 (12), pp. 6767-6789. Date of Electronic Publication: 2026 Jul 20 (Print Publication: 2026).
Τύπος έκδοσης: Journal Article; Review
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Ivyspring International Country of Publication: Australia NLM ID: 101235568 Publication Model: eCollection Cited Medium: Internet ISSN: 1449-2288 (Electronic) Linking ISSN: 14492288 NLM ISO Abbreviation: Int J Biol Sci Subsets: MEDLINE
Imprint Name(s): Original Publication: Lake Haven, N.S.W., Australia : Ivyspring International, c2004-
Ιατρικοί όροι (MeSH): Aging*/physiology , Cellular Senescence*/physiology , Cellular Senescence*/drug effects , Senotherapeutics*/therapeutic use, Humans ; Animals ; Epigenesis, Genetic ; Apoptosis
Περίληψη: With the acceleration of global population aging, the pathological accumulation of senescent cells (SnCs) has been confirmed as the core biological mechanism driving multiple aging-related diseases. This article aims to systematically review the formation mechanism of SnCs and their pathological roles in various tissue lesions, and to specifically evaluate the progress of three cutting-edge intervention strategies (Senolytics, Immuno-senolytics and Senomorphics). Senolytics selectively induces programmed apoptosis in SnCs by antagonizing senescent cell anti-apoptotic pathways. Immuno-senolytics include vaccines, engineered cell therapy and specific antibodies, which utilize the immune surveillance mechanism to achieve efficient elimination of SnCs. Senomorphics precisely reshape the SASP profile by targeting signaling axis or interfering with epigenetic modifications. Although the strategies have demonstrated remarkable potential for reversing pathology, their clinical translation still faces challenges such as the heterogeneity of SnCs, the lack of specific markers, and potential off-target toxicity. Future research should focus on multidisciplinary collaboration, aiming to optimize spatiotemporal targeted delivery systems and combination drug regimens to build a safer and more precise anti-senescence treatment system.
(© The author(s).)
Competing Interests: Competing Interests: The authors have declared that no competing interest exists.
References: Cell. 2022 May 12;185(10):1630-1645. (PMID: 35504280)
Phytother Res. 2025 Apr 21;:. (PMID: 40259678)
Nat Commun. 2020 May 21;11(1):2549. (PMID: 32439975)
Cells. 2022 Mar 17;11(6):. (PMID: 35326467)
EBioMedicine. 2019 Jul;45:588-605. (PMID: 31285188)
Nat Aging. 2021 Dec;1(12):1117-1126. (PMID: 37117524)
J Adv Res. 2025 Apr;70:405-422. (PMID: 38744403)
Drug Des Devel Ther. 2025 Sep 19;19:8489-8522. (PMID: 40994903)
Nat Commun. 2019 Oct 21;10(1):4731. (PMID: 31636264)
Int J Mol Sci. 2023 Jan 25;24(3):. (PMID: 36768689)
Cell Res. 2023 Mar;33(3):197-198. (PMID: 36481795)
Nature. 2005 Jun 2;435(7042):677-81. (PMID: 15902208)
Biochem Pharmacol. 2019 Apr;162:250-261. (PMID: 30668936)
Lancet Healthy Longev. 2022 Jan;3(1):e67-e77. (PMID: 36098323)
Bone. 2019 Apr;121:121-133. (PMID: 30659978)
Biomolecules. 2025 Jun 13;15(6):. (PMID: 40563501)
Stem Cell Res Ther. 2025 Jan 23;16(1):23. (PMID: 39849576)
Oncol Lett. 2021 Oct;22(4):743. (PMID: 34466155)
Front Nutr. 2022 Sep 08;9:958563. (PMID: 36159455)
Acc Chem Res. 2020 May 19;53(5):1046-1055. (PMID: 32233400)
Aging Cell. 2021 Sep;20(9):e13447. (PMID: 34355491)
EBioMedicine. 2017 Jul;21:21-28. (PMID: 28416161)
Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):E4612-E4620. (PMID: 28533362)
Exp Gerontol. 2022 Jun 15;163:111800. (PMID: 35398171)
Sci Adv. 2019 Jun 05;5(6):eaaw0254. (PMID: 31183403)
Regen Ther. 2020 Feb 24;14:177-183. (PMID: 32128354)
J Neuroinflammation. 2023 Sep 11;20(1):208. (PMID: 37697347)
Oncogene. 2003 Nov 24;22(53):8590-607. (PMID: 14634621)
Trends Mol Med. 2020 Mar;26(3):243-245. (PMID: 31983612)
Mol Cancer Res. 2022 May 4;20(5):770-781. (PMID: 35046109)
Acta Biochim Biophys Sin (Shanghai). 2024 May 27;56(7):1055-1064. (PMID: 38804044)
Front Cell Dev Biol. 2020 Aug 25;8:836. (PMID: 32984331)
Front Immunol. 2026 Mar 30;17:1734880. (PMID: 41983134)
Sci Rep. 2022 Apr 20;12(1):6522. (PMID: 35444208)
Aging Cell. 2025 Aug;24(8):e70114. (PMID: 40437670)
Nat Cell Biol. 2024 Aug;26(8):1336-1345. (PMID: 39103548)
Cell Mol Life Sci. 2021 Dec;78(23):7757-7776. (PMID: 34714358)
Sci Rep. 2019 Mar 1;9(1):3306. (PMID: 30824767)
Cell. 2023 Jan 19;186(2):243-278. (PMID: 36599349)
Phytother Res. 2021 Oct;35(10):5767-5780. (PMID: 34374127)
Cells. 2024 Jul 31;13(15):. (PMID: 39120322)
Oxid Med Cell Longev. 2021 Jul 11;2021:9932218. (PMID: 34336123)
Nat Commun. 2017 Sep 4;8(1):422. (PMID: 28871086)
J Med Chem. 2024 Sep 12;67(17):15756-15779. (PMID: 39172064)
Lancet. 2025 Oct 18;406(10513):1731-1810. (PMID: 41092927)
Neuron. 2025 Jan 8;113(1):29-48. (PMID: 39406236)
Aging Cell. 2019 Jun;18(3):e12950. (PMID: 30907060)
Expert Opin Emerg Drugs. 2011 Mar;16(1):59-70. (PMID: 20812891)
Aging (Albany NY). 2020 Apr 8;12(7):6401-6414. (PMID: 32268299)
Proteomics. 2020 Mar;20(5-6):e1800404. (PMID: 32131138)
Nat Med. 2017 Jun;23(6):775-781. (PMID: 28436958)
Cells. 2021 Sep 19;10(9):. (PMID: 34572131)
Sci Transl Med. 2019 Mar 6;11(482):. (PMID: 30842316)
J Exp Med. 2018 May 7;215(5):1287-1299. (PMID: 29622565)
EBioMedicine. 2019 Sep;47:446-456. (PMID: 31542391)
Drugs. 2017 Apr;77(5):521-546. (PMID: 28255960)
Nat Aging. 2024 Mar;4(3):336-349. (PMID: 38267706)
Biochem Soc Trans. 2018 Oct 19;46(5):1213-1224. (PMID: 30287511)
Cell Cycle. 2018;17(9):1048-1055. (PMID: 29886783)
Exp Mol Med. 2020 Dec;52(12):2034-2045. (PMID: 33318630)
Chem Biol Interact. 2023 Aug 1;380:110540. (PMID: 37169278)
Sci Adv. 2025 Mar 21;11(12):eadj1896. (PMID: 40106554)
Mech Ageing Dev. 2024 Dec;222:111995. (PMID: 39384074)
Science. 2022 Aug 19;377(6608):eabk0637. (PMID: 35981040)
Front Bioeng Biotechnol. 2021 Apr 29;9:677576. (PMID: 33996787)
Sci Transl Med. 2021 May 19;13(594):. (PMID: 34011625)
Exp Mol Med. 2018 Sep 19;50(9):1-10. (PMID: 30232322)
Mol Cancer. 2023 Jan 30;22(1):20. (PMID: 36717905)
Int J Mol Sci. 2021 Mar 29;22(7):. (PMID: 33805567)
Cell Metab. 2023 Apr 4;35(4):667-684.e6. (PMID: 37019080)
Gerontology. 1985;31(4):215-35. (PMID: 3902578)
Circ Res. 2024 Feb 2;134(3):307-324. (PMID: 38179698)
Biomed Pharmacother. 2021 Nov;143:112164. (PMID: 34649335)
Cell Oncol (Dordr). 2025 Apr;48(2):351-371. (PMID: 39633108)
Ageing Res Rev. 2023 Apr;86:101860. (PMID: 36682465)
Nat Med. 2015 Dec;21(12):1424-35. (PMID: 26646499)
Aging Cell. 2020 Nov;19(11):e13267. (PMID: 33219735)
Molecules. 2020 Oct 12;25(20):. (PMID: 33053864)
Mech Ageing Dev. 2022 Dec;208:111740. (PMID: 36150603)
Geroscience. 2024 Apr;46(2):1641-1655. (PMID: 37713088)
Sci Transl Med. 2024 Aug 28;16(762):eadj9366. (PMID: 39196958)
Comput Biol Med. 2024 Sep;180:108776. (PMID: 39089116)
Trends Genet. 2022 Jul;38(7):676-707. (PMID: 35504755)
Inflamm Res. 2024 Jan;73(1):65-82. (PMID: 38062164)
Pharm Biol. 2023 Dec;61(1):288-297. (PMID: 36815239)
Mol Cancer. 2013 Oct 24;12(1):128. (PMID: 24156782)
Cell Rep Med. 2025 Jul 15;6(7):102209. (PMID: 40602406)
J Clin Invest. 2022 Aug 1;132(15):. (PMID: 35912854)
Front Immunol. 2022 Dec 09;13:1033672. (PMID: 36569952)
Mol Neurobiol. 2021 Aug;58(8):3848-3862. (PMID: 33860440)
Free Radic Biol Med. 2018 Feb 20;116:88-100. (PMID: 29325896)
Circulation. 2023 Feb 21;147(8):650-666. (PMID: 36515093)
Semin Immunol. 2021 Aug;56:101580. (PMID: 34920941)
Trends Mol Med. 2022 Feb;28(2):97-109. (PMID: 35012887)
Adv Pharmacol. 2025;104:1-35. (PMID: 40716927)
Biomed Pharmacother. 2024 Oct;179:117433. (PMID: 39260327)
Sci Transl Med. 2022 Nov 23;14(672):eabp8309. (PMID: 36417485)
Hypertens Res. 2008 Apr;31(4):757-65. (PMID: 18633188)
Adv Sci (Weinh). 2025 Mar;12(9):e2415902. (PMID: 39792782)
Arch Toxicol. 2023 Oct;97(10):2499-2574. (PMID: 37597078)
J Clin Oncol. 2008 Sep 1;26(25):4180-8. (PMID: 18757333)
Cells. 2019 Jan 19;8(1):. (PMID: 30669451)
Nature. 2020 Jul;583(7814):127-132. (PMID: 32555459)
Oncotarget. 2017 May 30;8(22):35492-35507. (PMID: 28548953)
Invest Ophthalmol Vis Sci. 2019 Nov 1;60(14):4643-4651. (PMID: 31682715)
Cancer Res. 1995 Jun 1;55(11):2284-92. (PMID: 7757977)
Signal Transduct Target Ther. 2023 May 13;8(1):200. (PMID: 37179335)
Free Radic Biol Med. 2021 Aug 1;171:169-190. (PMID: 33989756)
Cancer Res. 2008 May 1;68(9):3421-8. (PMID: 18451170)
Nat Med. 2022 Aug;28(8):1556-1568. (PMID: 35953721)
Sci Rep. 2025 Mar 29;15(1):10905. (PMID: 40158057)
Crit Rev Food Sci Nutr. 2022;62(13):3509-3534. (PMID: 33377391)
Aging (Albany NY). 2017 Mar 8;9(3):955-963. (PMID: 28273655)
Pharmacol Res. 2024 Mar;201:107063. (PMID: 38216006)
Cell. 2024 Jul 25;187(15):4030-4042.e13. (PMID: 38908367)
Front Nutr. 2023 Sep 19;10:1237869. (PMID: 37794966)
Front Immunol. 2022 Jul 22;13:943321. (PMID: 35935939)
Int J Mol Sci. 2024 Sep 07;25(17):. (PMID: 39273655)
Genes Dev. 2020 Dec 1;34(23-24):1565-1576. (PMID: 33262144)
Iran J Basic Med Sci. 2024;27(9):1105-1114. (PMID: 39055870)
Antioxidants (Basel). 2023 Aug 21;12(8):. (PMID: 37627641)
Nature. 2024 Sep;633(8030):634-645. (PMID: 39198642)
Nat Cell Biol. 2022 Feb;24(2):135-147. (PMID: 35165420)
Commun Biol. 2025 Feb 24;8(1):299. (PMID: 39994346)
Am J Respir Crit Care Med. 2021 Mar 15;203(6):707-717. (PMID: 32991815)
Eur J Immunol. 2023 Aug;53(8):e2250353. (PMID: 37179252)
Cell Stem Cell. 2021 Jun 3;28(6):1057-1073.e7. (PMID: 33571444)
Molecules. 2022 Aug 19;27(16):. (PMID: 36014530)
Geroscience. 2023 Oct;45(5):2769-2783. (PMID: 37801202)
Aging Cell. 2016 Jun;15(3):428-35. (PMID: 26711051)
Histochem Cell Biol. 2018 Dec;150(6):711-719. (PMID: 30159784)
Biomed Pharmacother. 2021 Jan;133:110972. (PMID: 33254021)
Cancer Res. 2017 Jan 15;77(2):343-354. (PMID: 27793846)
Nat Commun. 2024 Jul 6;15(1):5670. (PMID: 38971872)
Aging Dis. 2024 Apr 1;15(2):612-639. (PMID: 37450933)
Theranostics. 2024 Aug 26;14(14):5429-5442. (PMID: 39310100)
Theranostics. 2024 Jan 20;14(3):1224-1240. (PMID: 38323313)
Lancet Healthy Longev. 2024 Feb;5(2):e152-e162. (PMID: 38310895)
Front Immunol. 2025 Apr 04;16:1565278. (PMID: 40255394)
Aging Cell. 2023 Oct;22(10):e13948. (PMID: 37548098)
Sci Transl Med. 2023 Aug 16;15(709):eadd1951. (PMID: 37585504)
EBioMedicine. 2018 Oct;36:18-28. (PMID: 30279143)
Cell Rep. 2022 Sep 20;40(12):111396. (PMID: 36130505)
Nat Metab. 2019 Nov;1(11):1074-1088. (PMID: 31799499)
Nat Rev Drug Discov. 2017 Apr;16(4):273-284. (PMID: 28209992)
Front Immunol. 2022 Jun 13;13:882407. (PMID: 35769461)
Ageing Res Rev. 2015 May;21:1-15. (PMID: 25625901)
Front Immunol. 2021 Jun 07;12:682853. (PMID: 34163481)
Am J Respir Cell Mol Biol. 2025 Aug;73(2):210-220. (PMID: 39836066)
Ecotoxicol Environ Saf. 2022 Dec 1;247:114266. (PMID: 36334339)
Nat Aging. 2021 Oct;1(10):870-879. (PMID: 34841261)
Aging (Albany NY). 2020 Dec 22;12(24):25138-25152. (PMID: 33350983)
J Med Chem. 2021 Jun 24;64(12):8010-8041. (PMID: 34107682)
Ann Rheum Dis. 2021 Jul;80(7):865-875. (PMID: 33741556)
Nat Commun. 2017 Feb 23;8:14532. (PMID: 28230051)
Aging (Albany NY). 2021 Jul 12;13(14):17978-18005. (PMID: 34253688)
Hepatology. 2023 Jun 1;77(6):1998-2015. (PMID: 36815382)
Cancer Res. 2016 Jun 15;76(12):3446-50. (PMID: 27256564)
Iran J Basic Med Sci. 2013 May;16(5):710-8. (PMID: 23826494)
Aging Cell. 2022 Jun;21(6):e13646. (PMID: 35645319)
Ageing Res Rev. 2023 Jul;88:101943. (PMID: 37142059)
J Clin Invest. 2018 Apr 2;128(4):1208-1216. (PMID: 29457783)
J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):3137-3148. (PMID: 36218080)
Aging Cell. 2024 Oct;23(10):e14258. (PMID: 39012326)
Nat Commun. 2019 Jun 3;10(1):2387. (PMID: 31160572)
Front Immunol. 2023 Sep 25;14:1226518. (PMID: 37818365)
Ageing Res Rev. 2024 Nov;101:102502. (PMID: 39278272)
Trends Cell Biol. 2024 Aug;34(8):626-635. (PMID: 38220548)
Sci Adv. 2024 Mar;10(9):eadj2102. (PMID: 38416816)
Osteoarthritis Cartilage. 2021 Mar;29(3):413-422. (PMID: 33242601)
Clin Exp Pharmacol Physiol. 2019 May;46(5):413-422. (PMID: 30754072)
Hum Vaccin Immunother. 2025 Dec;21(1):2479229. (PMID: 40088037)
Theranostics. 2021 Mar 4;11(10):4710-4727. (PMID: 33754023)
J Thorac Oncol. 2024 Aug;19(8):1186-1200. (PMID: 38553005)
Semin Immunol. 2018 Dec;40:101275. (PMID: 31088710)
Front Immunol. 2022 Aug 18;13:935114. (PMID: 36059455)
Curr Biol. 2022 Nov 7;32(21):4719-4726.e4. (PMID: 36137547)
Nat Neurosci. 2019 May;22(5):719-728. (PMID: 30936558)
Cells. 2022 Apr 04;11(7):. (PMID: 35406777)
FEBS J. 2023 Mar;290(5):1348-1361. (PMID: 35106956)
Aging Cell. 2022 Oct;21(10):e13707. (PMID: 36087066)
Int J Biol Macromol. 2020 Oct 15;161:1086-1098. (PMID: 32561284)
Front Public Health. 2023 Oct 13;11:1253506. (PMID: 37900047)
Sci Immunol. 2020 Mar 20;5(45):. (PMID: 32198222)
FEBS J. 2023 Mar;290(5):1362-1383. (PMID: 35015337)
Cancer Res. 2022 Dec 16;82(24):4670-4679. (PMID: 36222720)
Aging Cell. 2021 Apr;20(4):e13338. (PMID: 33711211)
Int J Mol Sci. 2021 Apr 08;22(8):. (PMID: 33917737)
Cell Mol Life Sci. 2019 May;76(10):1901-1918. (PMID: 30788516)
Biochem Soc Trans. 2020 Jun 30;48(3):765-773. (PMID: 32369550)
Aging (Albany NY). 2021 Sep 16;13(18):21838-21854. (PMID: 34531331)
Korean J Physiol Pharmacol. 2021 Jul 1;25(4):297-305. (PMID: 34187948)
Aging Cell. 2025 Dec;24(12):e70257. (PMID: 41201238)
Lancet. 2025 Aug 30;406(10506):940-949. (PMID: 40885585)
Med Res Rev. 2020 Nov;40(6):2114-2131. (PMID: 32578904)
Int J Mol Sci. 2017 Sep 15;18(9):. (PMID: 28914798)
Acta Pharmacol Sin. 2024 Feb;45(2):268-281. (PMID: 37674042)
Dev Cell. 2014 Dec 22;31(6):722-33. (PMID: 25499914)
J Transl Med. 2023 Sep 23;21(1):660. (PMID: 37742034)
Int J Mol Sci. 2025 Jun 04;26(11):. (PMID: 40508198)
JOR Spine. 2025 Mar 05;8(1):e70044. (PMID: 40046265)
EBioMedicine. 2020 Sep;59:102975. (PMID: 32853984)
J Agric Food Chem. 2023 Nov 22;71(46):17597-17614. (PMID: 37934032)
Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a001651. (PMID: 20457564)
JCI Insight. 2021 Dec 8;6(23):. (PMID: 34877934)
Eur Heart J. 2024 Oct 14;45(39):4219-4235. (PMID: 39088352)
Biomed Pharmacother. 2021 May;137:111327. (PMID: 33545662)
Toxicology. 2023 May 15;490:153511. (PMID: 37059347)
Biofactors. 2021 Mar;47(2):170-180. (PMID: 33368702)
Mol Cancer Res. 2021 May;19(5):874-885. (PMID: 33500359)
Int J Mol Sci. 2023 May 18;24(10):. (PMID: 37240299)
Nutrients. 2022 Oct 16;14(20):. (PMID: 36297010)
Aging Cell. 2024 Aug;23(8):e14184. (PMID: 38687090)
Transl Res. 2024 Dec;274:101-117. (PMID: 39424127)
Autophagy. 2024 Sep;20(9):2000-2016. (PMID: 38762757)
Front Endocrinol (Lausanne). 2022 Jun 28;13:924299. (PMID: 35837297)
J Adv Res. 2025 Feb;68:179-200. (PMID: 38462039)
Curr Top Med Chem. 2019;19(12):1005-1040. (PMID: 30827245)
Nat Aging. 2024 Sep;4(9):1231-1248. (PMID: 38951692)
Int J Mol Sci. 2021 Jan 08;22(2):. (PMID: 33435578)
Int J Mol Sci. 2023 Nov 17;24(22):. (PMID: 38003658)
NPJ Aging. 2025 Feb 21;11(1):12. (PMID: 39984468)
Biogerontology. 2016 Apr;17(2):305-15. (PMID: 26400758)
J Clin Invest. 2018 Apr 2;128(4):1238-1246. (PMID: 29608137)
Nat Rev Mol Cell Biol. 2021 Feb;22(2):75-95. (PMID: 33328614)
Biomedicines. 2023 Jul 23;11(7):. (PMID: 37509711)
Nature. 2023 Aug;620(7973):374-380. (PMID: 37532932)
Cell Death Discov. 2024 Jun 15;10(1):288. (PMID: 38879630)
Int J Mol Sci. 2025 Feb 20;26(5):. (PMID: 40076436)
Nat Commun. 2016 Apr 06;7:11190. (PMID: 27048913)
Osteoarthritis Cartilage. 2019 Jun;27(6):965-976. (PMID: 30716534)
Immunity. 2025 Apr 8;58(4):811-825.e7. (PMID: 40203808)
Aging Cell. 2024 Mar;23(3):e14060. (PMID: 38062873)
Arthritis Res Ther. 2021 Apr 16;23(1):117. (PMID: 33863359)
Oncogene. 2008 Oct 27;27(50):6398-406. (PMID: 18955968)
Contributed Indexing: Keywords: cellular senescence; epigenetic regulation; immuno-senolytics; senolytics; senomorphics
Substance Nomenclature: 0 (Senotherapeutics)
Entry Date(s): Date Created: 20260729 Date Completed: 20260729 Latest Revision: 20260813
Update Code: 20260814
PubMed Central ID: PMC13412423
DOI: 10.7150/ijbs.138243
PMID: 42524598
Βάση Δεδομένων: MEDLINE